PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease

✍ Scribed by Rosser, G.; Tricoci, P.; Morrow, D.; Christopoulos, C.; Niespialowska-Steuden, M. N.; Kozarski, R.; Wilcox, R.; Gorog, D. A.

• Book ID: 125369735
• Publisher: Springer US
• Year: 2014
• Tongue: English
• Weight: 228 KB
• Volume: 38
• Category: Article
• ISSN: 0929-5305
• DOI: 10.1007/s11239-014-1075-4